Biotech · Private company · Atlanta, GA, US

Cambium Oncology LLC

Track this companyFree. Adds Cambium Oncology LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Development of a Novel Immunotherapeutic for Acute Myeloid LeukemiaFiscal year 2026 · $1.1MNIH RePORTER 5R44CA285206-03 · fetched Nov 12, 2026
Development of a Novel Armored CAR-T Immunotherapeutic for Pancreatic CancerFiscal year 2025 · $400.8KNIH RePORTER 1R44CA298704-01 · fetched Nov 12, 2026
Development of a Novel Immunotherapeutic for Acute Myeloid LeukemiaFiscal year 2025 · $1MNIH RePORTER 4R44CA285206-02 · fetched Nov 12, 2026
Development of a Novel Immunotherapeutic for Acute Myeloid LeukemiaFiscal year 2024 · $405KNIH RePORTER 1R44CA285206-01A1 · fetched Nov 12, 2026